Atherectomy is an excision or removal of an atheroma. It is a procedure that utilizes a catheter with a sharp blade on the end to remove plaque from blood vessels.

The global atherectomy devices market report has been segmented on the basis of type, application, end user, and region. Increasing prevalence of cardiovascular diseases and increasing preference for minimally invasive surgical procedures are major factor expected to boost the growth of the global atherectomy devices market over the forecast period. In addition, favorable medical reimbursements are another major factor expected to boost the growth of the market. However, adoption of alternative therapies, stringent government regulation, and lack of well-trained surgeons are major factors expected to hamper the growth of the market over the forecast period.

Based on type, the global atherectomy devices market is segmented based on directional atherectomy, rotational atherectomy, orbital atherectomy, and laser atherectomy. The directional atherectomy devices segment is expected to account major revenue share of the market. This is attributed to increasing number of approvals for the devices and availability of the product in various sizes.

Request Sample Copy of the Report: https://marketresearch.biz/report/atherectomy-devices-market/request-sample/

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the increasing number of product approvals by health authorities of US and Canada. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India, China is expected to support the growth of Asia Pacific market, owing to increasing number of cases of cardiovascular diseases in the region.

Some prominent players in the global atherectomy devices market are Koninklijke Philips N.V., Medtronic Plc, Cardiovascular Systems, Inc., Boston Scientific Corporation, C.R. Bard Inc., Minnetronix, Inc., Avinger Inc., B. Braun Melsungen AG, Abbott Laboratories, and Volcano Corporation.